Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oracle Corporation (ORCL) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

Oracle CorporationTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Oracle Corporation vs Relay Therapeutics Inc. Common Stock — how do they compare? Oracle Corporation trades at $137 (market cap $411.34B), while Relay Therapeutics Inc. Common Stock trades at $17.59 (market cap $3.82B). The key difference: Oracle Corporation is far larger — about 107.7× Relay Therapeutics Inc. Common Stock's market cap, and Oracle Corporation pays a 1.47% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oracle Corporation for 72 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

ORCLRLAY
Market Cap
$411.34B$3.82B
Volume
41,276,8154,332,079
Sector
TechnologyHealth
52-Week High
$313.00$20.75
52-Week Low
$114.99$6.03
Typical Hold Time
72 Days0 Days
Enterprise Value
$535.15B$2.93B
Dividend Yield
1.47%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oracle Corporation

Oracle (ORCL) trades at $143.56, down 0.83% amid a bearish technical signal, though recent earnings consistently beat expectations with Q2 2026 EPS of $1.92 versus $1.74 expected. The company shows strong fundamentals with 2025 revenue of $57.40B and net income margin of 26.36%, while analyst consensus remains bullish with a $236.52 price target. News highlights AI cloud growth of 120% in Q1 2026 but also layoffs and market concerns over AI spending cycles.

The outlook is mixed: robust AI-driven revenue growth and high profitability support upside, but technical weakness and macroeconomic risks like Fed policy pose near-term headwinds. Investors face opportunity from AI demand against volatility from high debt and competitive pressures.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORCL
57% Buy43% Sell
Avg holding period · 72 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

Read more on ORCL →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →